PHGUF News and Press, Pharming Group Nv Ord From 08/06/23

2023-08-06 02:54:01 ET Pharming Group N.V. (PHGUF) Q2 2023 Earnings Conference Call August 03, 2023 07:30 AM ET Company Participants Sijmen de Vries - CEO Anurag Relan - CMO Stephen Toor - CCO Jeroen Wakkerman - CFO Conference Call Participants Ch...

2023-08-04 06:36:21 ET Pharming Group N.V. press release ( OTCPK:PHGUF ): Q2 Revenue of $54.9M. cash and cash equivalents, including restricted cash, of US$194.1 million at the end of 2Q 2023, compared to US$186.2 million at end of 1Q 2023 For further det...

2023-05-11 14:44:06 ET Pharming Group N.V. (PHGUF) Q1 2023 Earnings Conference Call May 11, 2023 8:30 AM ET Company Participants Sijmen de Vries – Chief Executive Officer Anurag Relan – Chief Medical Officer Stephen Toor – Chief Commercial Of...

2023-05-11 10:05:51 ET Pharming Group N.V. ( OTCPK:PHGUF ): Q1 GAAP EPS of $0.02. Revenue of $42.5M (-8.8% Y/Y) misses by $6M . For further details see: Pharming Group N.V. GAAP EPS of $0.02, revenue of $42.5M misses by $6M

2023-03-27 05:45:26 ET The shares of Dutch biotech Pharming Group N.V. ( NASDAQ: PHAR ) added ~24% on Monday in the Amsterdam stock exchange on the announcement of U.S. approval for the rare immune disorder therapy Joenja co-developed with Novartis ( NVS ). The FDA...

2023-03-16 10:04:06 ET Pharming Group N.V. (PHGUF) Q4 2022 Earnings Call Transcript March 16, 2023 08:30 AM ET Company Participants Sijmen de Vries - Executive Director & Chief Executive Officer Anurag Relan - Chief Medical Officer Jeroen Wakkerman - Chief Fi...

2023-03-16 08:53:37 ET The following slide deck was published by Pharming Group N.V. in conjunction with their 2022 Q4 earnings call. For further details see: Pharming Group N.V. 2022 Q4 - Results - Earnings Call Presentation

Pharming announces first patient enrolled in pediatric clinical trial of leniolisib Canada NewsWire The multinational Phase III study is evaluating leniolisib tablets in children aged 4 to 11 years with APDS, a rare primary immunodeficiency LEIDEN, Netherlands ...

Pharming Group N.V. (PHGUF) Q3 2022 Earnings Conference Call October 27, 2022 7:30 AM ET Company Participants Sijmen de Vries - Chief Executive Officer Anurag Relan - Chief Medical Officer Jeroen Wakkerman - Chief Financial Officer Conference Call Participa...

The European Medicines Agency (EMA) validated Pharming's ( NASDAQ: PHAR ) application seeking approval of leniolisib to treat patients aged 12 years and older with activated phosphoinositide 3-kinase (PI3K) delta syndrome (APDS). The company's marketing authorisation a...